Live Verdure Ltd

Healthcare AU LV1

0.515AUD
0.10(22.62%)

Last update at 2024-05-13T06:10:00Z

Day Range

0.430.59
LowHigh

52 Week Range

0.080.88
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Minority interest - - - - -
Net income -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Selling general administrative 4.24M 1.00M 2.25M 1.70M 0.51M
Selling and marketing expenses - 3.20M 1.22M - -
Gross profit 1.57M 1.44M 0.28M 0.56M 0.09M
Reconciled depreciation 0.04M 0.00562M 0.00702M - -
Ebit -2.71097M -3.10451M -3.22698M -1.20768M -0.44297M
Ebitda -2.66763M -3.09889M -3.21996M - -
Depreciation and amortization - 0.00562M 0.00702M - -
Non operating income net other - - - - -
Operating income -2.70926M -3.10451M -3.22698M -1.20605M -0.44626M
Other operating expenses -0.15208M 5.14M 3.96M -0.05076M 0.00292M
Interest expense 0.12M 0.86M 0.23M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.12M 0.86M 0.00125M 0.04M -
Net interest income -0.12325M -0.85853M -0.22916M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 1.01M 0.36M - -
Total revenue 2.41M 1.89M 0.61M 0.40M 0.23M
Total operating expenses - 4.70M 3.64M - -
Cost of revenue 0.84M 0.45M 0.33M -0.16112M 0.15M
Total other income expense net 0.19M 0.15M 0.13M - -
Discontinued operations - - - - -
Net income from continuing ops -2.83422M -3.96406M -3.45740M - -
Net income applicable to common shares -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2.49M 1.29M 4.17M 5.59M 1.04M
Intangible assets 1.18M - - - -
Earning assets - - - - -
Other current assets 0.00418M 0.00110M 0.00110M 0.10M 0.07M
Total liab 1.57M 0.92M 0.46M 0.36M 0.22M
Total stockholder equity 0.92M 0.36M 3.71M 5.23M 0.82M
Deferred long term liab - - - - -
Other current liab 0.70M 0.28M 0.13M 0.00652M -
Common stock 9.71M 7.05M 6.98M 7.00M 1.48M
Capital stock 9.71M 7.05M 6.98M 7.00M -
Retained earnings -12.23476M -9.40053M -5.43648M -3.87740M -0.65995M
Other liab 0.34M - 0.00590M 0.00115M 0.00327M
Good will - - - - -
Other assets - - - - -
Cash 0.17M 0.53M 3.66M 5.16M 0.17M
Cash and equivalents - - - - -
Total current liabilities 1.23M 0.92M 0.45M 0.35M 0.21M
Current deferred revenue - - - - -
Net debt - -0.53307M -3.65806M -5.11557M -
Short term debt 0.00000M 0.00000M 0.00000M 0.03M 0.00000M
Short long term debt - - - - -
Short long term debt total - - - 0.04M -
Other stockholder equity 3.44M 2.71M 2.16M - -
Property plant equipment 0.05M 0.02M 0.03M 0.04M 0.15M
Total current assets 1.27M 1.26M 4.14M 5.55M 0.89M
Long term investments - - - - -
Net tangible assets -0.25226M 0.36M 3.71M -0.28389M 0.82M
Short term investments 0.00418M 0.00110M 0.00110M - -
Net receivables 0.13M 0.10M 0.07M 0.06M 0.57M
Long term debt - - - - -
Inventory 0.92M 0.59M 0.36M 0.24M 0.07M
Accounts payable 0.44M 0.64M 0.32M 0.31M 0.20M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 2.71M 2.16M 2.11M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 1.23M 0.02M 0.03M 0.04M -
Capital lease obligations 0.04M - - 0.04M -
Long term debt total 0.00000M 0.00000M 0.00000M 0.01M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.74988M - - - -
Change to liabilities 0.27M 0.00000M 0.14M 0.08M 0.00000M
Total cashflows from investing activities -0.74988M -0.74988M -0.74988M -0.00412M -0.11018M
Net borrowings - - - 0.57M -0.35000M
Total cash from financing activities 3.12M 0.07M 4.99M 1.34M 0.55M
Change to operating activities -0.59131M 0.48M 0.03M -0.07223M -0.07223M
Net income -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Change in cash -0.36451M -3.12498M 3.51M -0.02267M 0.08M
Begin period cash flow 0.53M 3.66M 0.14M - -
End period cash flow 0.17M 0.53M 3.66M 0.14M -
Total cash from operating activities -2.73563M -3.19278M -1.47084M -1.35483M -0.36050M
Issuance of capital stock 3.38M 0.08M 5.50M - -
Depreciation 0.07M 0.00562M 0.00700M 0.08M 0.02M
Other cashflows from investing activities -0.74988M 0.00000M - 0.00000M -0.00875M
Dividends paid - - - - -
Change to inventory -0.32617M -0.23397M 0.06M -0.22470M -0.22470M
Change to account receivables -0.03257M -0.02422M 0.03M -0.01031M -0.01031M
Sale purchase of stock 3.38M -0.01336M -0.50891M 0.78M 0.95M
Other cashflows from financing activities -0.26400M -0.01336M -0.51438M -0.01165M -0.04715M
Change to netincome 0.70M 0.77M 1.72M 0.11M 0.07M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00412M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.73563M -3.19278M -1.47084M -1.35483M -0.36050M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -2.73563M -3.19278M -1.47084M - -

Fundamentals

  • Previous Close 0.42
  • Market Cap56.12M
  • Volume835476
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.31262M
  • Revenue TTM2.18M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 1.42M
  • Diluted EPS TTM-0.07

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LV1
Live Verdure Ltd
0.10 22.62% 0.52 - - 39.23 33.30 39.31 -13.3335
AFP
AFT Pharmaceuticals Ltd
0.19 7.31% 2.79 28.89 17.06 1.79 4.41 2.18 16.66
PBP
Probiotec Ltd
0.06 2.07% 2.96 28.70 - 1.06 2.64 1.39 8.58
VLS
Vita Life Sciences Ltd
0.04 1.95% 2.09 12.94 - 1.73 2.97 1.41 7.98
NXS
Next Science Ltd
-0.01 2.56% 0.38 - 128.21 4.47 5.03 3.90 -5.9908

Reports Covered

Stock Research & News

Profile

Live Verdure Ltd, a health, wellness, and skincare company, engages in the development of range of naturally-based products in Australia. It offers hemp-based food, beauty and nutraceutical products, and skincare products under the 13 Seeds, 8 Seeds, and Edible Beauty Australia brand names through wholesale, distribution, retail, and online channels. The company was formerly known as 13 Seeds Ltd. and changed its name to Live Verdure Limited in October 2020. Live Verdure Ltd was incorporated in 2016 and is based in Melbourne, Australia.

Live Verdure Ltd

459 Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Sec. NA
Mr. Jonathan Do Chief Technical Officer NA
Mr. Asaf Katz Head of Online Growth NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Secretary NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Secretary NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Secretary NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).